🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial is studying how well aflibercept works in treating pati...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2007-09
Trial ID
NCT00509249
Treatments Being Tested
This is a multi centre, single arm, prospective observational phase 4 study...
Status
Unknown
Location
Chu de Poitiers
Start Date
2018-06-22
Trial ID
NCT03797547
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of fari...
Status
Completed
Location
Associated Retina Consultants
Start Date
2018-10-09
Trial ID
NCT03622593
Treatments Being Tested
A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled,...
Status
Terminated
Location
COAST Investigational Site
Start Date
2021-03-12
Trial ID
NCT04757636
Treatments Being Tested
In this cross-sectional study of patients with wet AMD who received ≥1 anti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05110209
Treatments Being Tested
To demonstrate the effects of Lucentis (ranibizumab), Avastin ( bevacizumab...
Status
Unknown
Location
East Florida Eye Institute
Start Date
2014-12
Trial ID
NCT02296567
This study will describe and estimate the incidence of RV events among pati...
Status
Completed
Location
Regeneron Research Site
Start Date
2025-07-01
Trial ID
NCT06769412
Treatments Being Tested
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-4517...
Status
Active Not Recruiting
Location
Macro Trials
Start Date
2022-08-31
Trial ID
NCT05387837
Treatments Being Tested
Aflibercept (EYLEA®) induces a rapid reduction in central retinal thickness...
Status
Completed
Location
Service d'ophtalmologie Hôpital Henri Mondor 40, avenue de Verdun
Start Date
2014-09
Trial ID
NCT02246829
Treatments Being Tested
The AMALTHEA (Aflibercept MAintenance after first-Line THErapy with FOLFIRI...
Status
Completed
Location
Agios Georgios Chania General Hospital
Start Date
2014-05-26
Trial ID
NCT02129257
Treatments Being Tested